Log in
If you're happy with stocks yielding you 4% or 5% a year, you don't need this. But if you want to see how we built a portfolio that now pays us a 67% cash on cash return - with no leverage, options, or gimmicks.

BioTelemetry Price Target & Analyst Ratings (NASDAQ:BEAT)

-1.15 (-2.08 %)
(As of 01/21/2020 06:20 AM ET)
Today's Range
Now: $54.12
50-Day Range
MA: $47.99
52-Week Range
Now: $54.12
Volume352,567 shs
Average Volume232,455 shs
Market Capitalization$1.83 billion
P/E Ratio50.58
Dividend YieldN/A

Analyst Ratings

BioTelemetry (NASDAQ:BEAT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
6 Wall Street analysts have issued ratings and price targets for BioTelemetry in the last 12 months. Their average twelve-month price target is $72.67, suggesting that the stock has a possible upside of 34.27%. The high price target for BEAT is $87.00 and the low price target for BEAT is $54.00. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.802.803.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $72.67$75.60$77.60$78.83
Price Target Upside: 34.27% upside75.81% upside74.42% upside38.06% upside

BioTelemetry (NASDAQ:BEAT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.


And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.

BioTelemetry (NASDAQ:BEAT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/7/2020SunTrust BanksInitiated CoverageBuy$58.00High
11/6/2019Lake Street CapitalReiterated RatingBuy$90.00 ➝ $80.00High
8/2/2019Raymond JamesDowngradeOutperform ➝ Market PerformHigh
7/31/2019SidotiLower Price TargetBuy$95.00 ➝ $87.00Medium
4/26/2019Dougherty & CoReiterated RatingBuy ➝ Buy$81.00 ➝ $75.00Low
4/2/2019BenchmarkSet Price TargetBuy$82.00Low
(Data available from 1/21/2018 forward)
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel